ArticleOral diseases2026
Pretreatment C-Reactive Protein/Albumin Ratio Can Predict Severity of Radiotherapy-Induced Oral Mucositis in Advanced Laryngeal Cancer Patients.
Article in Oral diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTreatment methods of laryngeal cancer (LC) often include radiotherapy (RT), commonly combined with cytotoxic drugs. This approach is associated with early adverse effects, notably oral mucositis (OM). The C-reactive protein to albumin ratio (CAR) is a promising novel biomarker used to assess the severity of inflammatory responses in various chronic conditions. The aim of this study was to evaluate the predictive value of pretreatment CAR for the occurrence and severity of OM of varying grades during RT in patients with LC.
methodsThe pretreatment CAR values were calculated in 68 patients treated with RT due to locally advanced or advanced LC.
resultsThe increased incidence of severe grade OM in LC patients between weeks III and VII of RT was significantly associated with higher CAR values. A high CAR was significantly correlated with an increased risk of grade 3 OM at the end of the III
conclusionsThe pretreatment CAR value indicates clinical utility in predicting the likelihood of severe OM induced by RT-based therapy in patients with LC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.